Sattarnezhad, N., Kockum, I., Thomas, O. G., Liu, Y., Ho, P. P., Barrett, A. K., . . . Lanz, T. V. (2025). Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controls. Proceedings of the National Academy of Sciences - PNAS, 122(11), e2424986122. https://doi.org/10.1073/pnas.2424986122
Citácia podle Chicago (17th ed.)Sattarnezhad, Neda, et al. "Antibody Reactivity Against EBNA1 and GlialCAM Differentiates Multiple Sclerosis Patients from Healthy Controls." Proceedings of the National Academy of Sciences - PNAS 122, no. 11 (2025): e2424986122. https://doi.org/10.1073/pnas.2424986122.
Citácia podľa MLA (8th ed.)Sattarnezhad, Neda, et al. "Antibody Reactivity Against EBNA1 and GlialCAM Differentiates Multiple Sclerosis Patients from Healthy Controls." Proceedings of the National Academy of Sciences - PNAS, vol. 122, no. 11, 2025, p. e2424986122, https://doi.org/10.1073/pnas.2424986122.